Format

Send to

Choose Destination
Gates Open Res. 2019 Jul 5;3:1504. doi: 10.12688/gatesopenres.13042.2. eCollection 2019.

Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up.

Author information

1
Centre for Global Public Health, Rady Faculty of Health Sciences, Community Health Sciences, University of Manitoba, Winnipeg, Canada.
2
Ashodaya Samithi, Mysore, India.
3
Durbar Mahila Samanawaya Committee, Kolkata, India.
4
Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
5
Department of Global Health, University of Washington, Seattle, USA.
6
Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
7
Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife, Nigeria.
8
New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria.
9
Department of Medicine, University of Jos, Jos, Nigeria.
10
Centre de recherche du CHU de Québec, Université Laval, Quebec, Canada.
11
Dispensaire IST, Centre de santé communal de Cotonou 1, Cotonou, Benin.
12
École Nationale de Formation des Techniciens Supérieurs en Santé Publique et en Surveillance Épidémiologique, Université de Parakou, Parakou, Benin.
13
Département de médecine sociale et préventive, Université Laval, Quebec, Canada.
14
Institut national de santé publique du Québec, Quebec, Canada.
15
Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation (IRESSEF), Dakar, Senegal.
16
Westat, Inc, Rockville, USA.
17
LVCT Health, Nairobi, Kenya.
18
Wits Reproductive Health and HIV Institute (WRHI), Johannesburg, South Africa.
19
Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
20
Bill & Melinda Gates Foundation, Washington, USA.
21
Bill & Melinda Gates Foundation, Seattle, USA.
#
Contributed equally

Abstract

Pre-exposure prophylaxis (PrEP) has emerged as a new HIV prevention strategy. A series of demonstration projects were conducted to explore the use of PrEP outside of clinical trial settings. Learning from the failures in community consultation and involvement in early oral tenofovir trials, these PrEP projects attempted to better engage communities and create spaces for community involvement in the planning and roll out of these projects. We briefly describe the community engagement strategies employed by seven Bill & Melinda Gates Foundation-funded PrEP demonstration projects and the lessons these projects offer for community engagement in PrEP implementation.

KEYWORDS:

HIV; demonstration projects; pre-exposure prophylaxis; prevention; serodiscordant couples; sex work

Supplemental Content

Full text links

Icon for F1000 Research Ltd Icon for PubMed Central
Loading ...
Support Center